Literature DB >> 8380388

Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue.

I Valverde1, E Mérida, E Delgado, M A Trapote, M L Villanueva-Peñacarrillo.   

Abstract

Specific binding of [125I]glucagon-like peptide-1(7-36)amide ([125I]GLP-1(7-36)amide) to solubilized rat adipose tissue membranes was found to be dependent on temperature, time, and membrane protein concentration and readily dissociated. GLP-1(1-36)amide, GLP-2, or glucagon (10(-6) M) did not compete with [125I]GLP-1(7-36)amide binding. Half-maximal binding was achieved with 8 x 10(-10) M unlabeled GLP-1(7-36)amide, and the Scatchard plot revealed the presence of high and low affinity binding sites with Kd values of approximately 0.6 and 20 nM, respectively. The binding capacity of [125I]GLP-1(7-36)amide was about 3 times higher than that of [125I]glucagon, while the high affinity Kd and the half-maximal binding of the two peptides were similar. The presence and abundance of GLP-1(7-36)amide receptors in fat tissue together with the previous findings that the peptide stimulates glycerol and cAMP production in rat adipocytes and stimulates fatty acid synthesis in explants of rat adipose tissue open the possibility that this insulinotropic intestinal peptide may also be involved in the regulation of lipid metabolism in health and disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380388     DOI: 10.1210/endo.132.1.8380388

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.

Authors:  C G Jolivalt; M Fineman; C F Deacon; R D Carr; N A Calcutt
Journal:  Diabetes Obes Metab       Date:  2011-11       Impact factor: 6.577

2.  Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.

Authors:  Y-S Lee; M-S Park; J-S Choung; S-S Kim; H-H Oh; C-S Choi; S-Y Ha; Y Kang; Y Kim; H-S Jun
Journal:  Diabetologia       Date:  2012-06-22       Impact factor: 10.122

3.  Glucagon-like peptide-1: a potent regulator of food intake in humans.

Authors:  J P Gutzwiller; B Göke; J Drewe; P Hildebrand; S Ketterer; D Handschin; R Winterhalder; D Conen; C Beglinger
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

4.  Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.

Authors:  M L Villanueva-Peñacarrillo; J Puente; A Redondo; F Clemente; I Valverde
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

Review 5.  The gut and food intake: an update for surgeons.

Authors:  E Näslund; P M Hellström; J G Kral
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

6.  Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors.

Authors:  Dominique Dardevet; Mary Courtney Moore; Catherine A DiCostanzo; Ben Farmer; Doss W Neal; Wanda Snead; Margaret Lautz; Alan D Cherrington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-07-28       Impact factor: 4.052

7.  GLP-1(7-36)amide binding in skeletal muscle membranes from streptozotocin diabetic rats.

Authors:  M L Villanueva-Peñacarrillo; E Delgado; D Vicent; E Mérida; A I Alcántara; I Valverde
Journal:  Endocrine       Date:  1995-09       Impact factor: 3.633

8.  Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.

Authors:  A D Dobrian; Q Ma; J W Lindsay; K A Leone; K Ma; J Coben; E V Galkina; J L Nadler
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-16       Impact factor: 4.310

9.  Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain.

Authors:  Randi Ugleholdt; Jens Pedersen; Maria Rosaria Bassi; Ernst-Martin Füchtbauer; Signe Marie Jørgensen; Hanne-Louise Kissow; Nikolaj Nytofte; Steen Seier Poulsen; Mette Marie Rosenkilde; Yutaka Seino; Peter Thams; Peter Johannes Holst; Jens Juul Holst
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

10.  Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

Authors:  D A D'Alessio; S E Kahn; C R Leusner; J W Ensinck
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.